Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Lyons

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology|June 8, 2024
Mast cell activation syndrome: Current understanding and research needsMariana Castells, Matthew P Giannetti, Matthew J Hamilton, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2019
GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjectsAvanti Desai, Kathryn Sowerwine, Yihui Liu, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2014
Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairmentYu Zhang, Xiaomin Yu, Mie Ichikawa, et al.
The Journal of Allergy and Clinical Immunology|April 18, 2021
Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemiaLiza Konnikova, Tanya O Robinson, Anna H Owings, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2024
A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccinationMuhammad B Khalid, Ellen Zektser, Eric Chu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative GroupGregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative GroupKarl Sotlar, Tracy I George, Philip Kluin, et al.
The Journal of Allergy and Clinical Immunology|March 22, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator ConferenceJason Gotlib, Tracy I George, Melody C Carter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM ConsortiumPolina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαTPeter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology|June 8, 2024
Mast cell activation syndrome: Current understanding and research needsMariana Castells, Matthew P Giannetti, Matthew J Hamilton, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2019
GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjectsAvanti Desai, Kathryn Sowerwine, Yihui Liu, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2014
Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairmentYu Zhang, Xiaomin Yu, Mie Ichikawa, et al.
The Journal of Allergy and Clinical Immunology|April 18, 2021
Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemiaLiza Konnikova, Tanya O Robinson, Anna H Owings, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2024
A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccinationMuhammad B Khalid, Ellen Zektser, Eric Chu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative GroupGregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative GroupKarl Sotlar, Tracy I George, Philip Kluin, et al.
The Journal of Allergy and Clinical Immunology|March 22, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator ConferenceJason Gotlib, Tracy I George, Melody C Carter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM ConsortiumPolina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαTPeter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
Pageof 10